Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Tamanna, Mst. Taskia |
---|---|
Beste egile batzuk: | Sharmin, Dr. Sabrina |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/18146 |
Antzeko izenburuak
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
nork: Hassan, Md. Muhtaz
Argitaratua: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
nork: Islam, Md. Irfath
Argitaratua: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
nork: Alim, Abdul
Argitaratua: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
nork: Parveen, Sanjana
Argitaratua: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
nork: Tabassum, Nadira
Argitaratua: (2024)